Intuitive Surgical (NASDAQ:ISRG) Trading Down 0.6% After Insider Selling

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) traded down 0.6% during mid-day trading on Tuesday following insider selling activity. The stock traded as low as $589.00 and last traded at $592.23. 187,308 shares were traded during trading, a decline of 90% from the average session volume of 1,792,521 shares. The stock had previously closed at $595.70.

Specifically, EVP Myriam Curet sold 408 shares of the stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 269 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on ISRG. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Piper Sandler restated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 0.3 %

The firm has a market capitalization of $210.01 billion, a P/E ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39. The company has a fifty day simple moving average of $556.91 and a 200 day simple moving average of $516.98.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently bought and sold shares of the company. ORG Wealth Partners LLC purchased a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $65,000. CX Institutional lifted its position in Intuitive Surgical by 1.5% in the 3rd quarter. CX Institutional now owns 1,873 shares of the medical equipment provider’s stock valued at $920,000 after acquiring an additional 28 shares in the last quarter. Creative Planning boosted its stake in Intuitive Surgical by 9.3% during the 3rd quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock valued at $33,839,000 after purchasing an additional 5,842 shares during the last quarter. Swedbank AB increased its holdings in shares of Intuitive Surgical by 1.7% in the 3rd quarter. Swedbank AB now owns 180,043 shares of the medical equipment provider’s stock worth $88,450,000 after purchasing an additional 2,944 shares in the last quarter. Finally, Petredis Investment Advisors LLC raised its stake in shares of Intuitive Surgical by 0.3% in the third quarter. Petredis Investment Advisors LLC now owns 11,694 shares of the medical equipment provider’s stock worth $5,745,000 after purchasing an additional 40 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.